AngioDynamics
AngioDynamics to Participate in the Canaccord Adams 29th Annual Growth Stock Conference
Published in Cancer Weekly, August 18th, 2009
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced that it will present at the Canaccord Adams 29th Annual Growth Stock Conference in Boston on August 12, 2009 at 4:30 p.m. Eastern Time. Jan Keltjens, President and CEO, and Joseph Gersuk, Executive Vice President and CFO of AngioDynamics, will review the Company's business strategy and historical financial results.
Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-08-18)
More Articles from Cancer Weekly
- Journal of the National Cancer Institute
AIDS patients face higher risk of HPV-related cancers as immunosuppression grows - ADVENTRX Pharmaceuticals, Inc.
ADVENTRX Narrows Prior Guidance on NDA Submission Timeline - American Society for Radiation Oncology
Breast Cancer Radiation Guidelines Called Positive Step - Arenavirus
Research from University of Buenos Aires provide new insights into arenavirus - Breast Cancer
Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody - Cancer
Project Zero Delay Accelerates Drug's Path to Clinical Trial - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
